← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 30, 2020Last known activity
Aug 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (13 distinct, 10 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
Recent trials (11)
- NCT07076641Lead sponsorPhase 3Aug 1, 2025
- NCT06451380Lead sponsorN/AJul 31, 2024
- NCT05687019Lead sponsorN/ASep 12, 2023
- NCT05667987Lead sponsorN/AFeb 1, 2023
- NCT05439213Lead sponsorN/AJun 22, 2022
- NCT05008731Lead sponsorPhase 3Oct 31, 2021
- NCT04755712Lead sponsorPhase 4Mar 22, 2021
- NCT05010876Lead sponsorPhase 2Feb 4, 2021
- NCT05031234Lead sponsorN/ADec 17, 2020
- NCT04394481Overall official - principal investigatorPhase 4Jun 30, 2020
- NCT04394481Lead sponsorPhase 4Jun 30, 2020
Details
- Last known activity
- Aug 1, 2025